Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

NETWORK × Has results × osimertinib × Clear all

Phase

Status

Sponsor Class

INDUSTRY 29 OTHER 6 NIH 4 NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Non Small Cell Lung Cancer Metastatic 1

Interventions

Radiotherapy 76 Cyclophosphamide 69 Cisplatin 69 Vincristine 49 Doxorubicin 47 Paclitaxel 44 Etoposide 43 Carboplatin 43 Filgrastim 37 Methotrexate 33 Prednisone 32 Platinum 29 Granulocyte Colony-Stimulating Factor 29 Cytarabine 27 Docetaxel 25 Dexamethasone 25 Radiotherapy, Intensity-Modulated 24 Gemcitabine 24 Radiotherapy, Conformal 23 Leucovorin 23 Fluorouracil 23 Radiation 21 Cetuximab 21 1,2-diaminocyclohexaneplatinum II citrate 21 Taxes 20 Irinotecan 20 Rituximab 17 merphos 16 Oxaliplatin 15 Bevacizumab 15

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03133546 2026-02-06

BOOSTER

ETOP IBCSG Partners Foundation

Phase 2 Completed

155 enrolled 23 charts

Non Small Cell Lung Cancer Metastatic

Data powered by HemOnc (CC BY 4.0) Colophon ⚡